# Luigi Naldi

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/luigi-naldi/

## Facts

| Field | Value |
| --- | --- |
| Citations | 136,325 |
| Field | Psoriasis: Treatment and Pathogenesis |
| h-index | 87 |
| i10-index | 308 |
| Last Known Institution | Centro Studi GISED |
| OpenAlex ID | https://openalex.org/A5080662298 |
| ORCID iD | 0000-0002-3160-2835 |
| Works | 635 |

## Researcher papers

- [The Global Burden of Skin Disease in 2010: An Analysis of the Prevalence and Impact of Skin Conditions](https://scholariq.org/papers/the-global-burden-of-skin-disease-in-2010-an-analysis-of-the-prevalence-and/)
- [Drug reaction with eosinophilia and systemic symptoms (DRESS): an original multisystem adverse drug reaction. Results from the prospective RegiSCAR study](https://scholariq.org/papers/drug-reaction-with-eosinophilia-and-systemic-symptoms-dress-an-original/)
- [European S3‐Guidelines on the systemic treatment of psoriasis vulgaris](https://scholariq.org/papers/european-s3-guidelines-on-the-systemic-treatment-of-psoriasis-vulgaris/)
- [Cigarette Smoking, Body Mass Index, and Stressful Life Events as Risk Factors for Psoriasis: Results from an Italian Case–Control Study](https://scholariq.org/papers/cigarette-smoking-body-mass-index-and-stressful-life-events-as-risk-factors-for/)
- [Prevalence of contact allergy in the general population in different European regions](https://scholariq.org/papers/prevalence-of-contact-allergy-in-the-general-population-in-different-european/)
- [Italian guidelines on the systemic treatments of moderate‐to‐severe plaque psoriasis](https://scholariq.org/papers/italian-guidelines-on-the-systemic-treatments-of-moderate-to-severe-plaque/)
- [Factors associated with adverse COVID-19 outcomes in patients with psoriasis—insights from a global registry–based study](https://scholariq.org/papers/factors-associated-with-adverse-covid-19-outcomes-in-patients-with-psoriasis/)
- [Randomized Clinical Trials for Psoriasis 1977–2000: The EDEN Survey](https://scholariq.org/papers/randomized-clinical-trials-for-psoriasis-1977-2000-the-eden-survey/)
- [Italian healthcare resource consumptions and direct costs of adults with atopic dermatitis before and after dupilumab treatment](https://scholariq.org/papers/italian-healthcare-resource-consumptions-and-direct-costs-of-adults-with-atopic/)

## Researcher topics

- [Psoriasis: Treatment and Pathogenesis](https://scholariq.org/topics/psoriasis-treatment-and-pathogenesis/)
- [Dermatology and Skin Diseases](https://scholariq.org/topics/dermatology-and-skin-diseases/)
- [Cutaneous Melanoma Detection and Management](https://scholariq.org/topics/cutaneous-melanoma-detection-and-management/)
- [Nonmelanoma Skin Cancer Studies](https://scholariq.org/topics/nonmelanoma-skin-cancer-studies/)
- [Autoimmune Bullous Skin Diseases](https://scholariq.org/topics/autoimmune-bullous-skin-diseases/)

## Researcher university

- [Centro Studi GISED](https://scholariq.org/institutions/centro-studi-gised/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.